Fresenius Medical Care: FDA 510(k) clearances across all its applicant names
FDA lists 201 510(k) clearances, 0 PMA and 0 De Novo decisions across the 11 applicant names Caduvo groups under Fresenius Medical Care, first 1984, latest 2026. Median 510(k) review time across these names: 116 days. Since 2017 the median was 168 days, against 180 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 6 | 124 |
| 2013 | 10 | 163 |
| 2014 | 11 | 104 |
| 2015 | 6 | 111 |
| 2016 | 2 | 88 |
| 2017 | 6 | 124 |
| 2018 | 7 | 90 |
| 2019 | 3 | 178 |
| 2020 | 8 | 267 |
| 2021 | 0 | — |
| 2022 | 6 | 257 |
| 2023 | 5 | 230 |
| 2024 | 7 | 184 |
| 2025 | 12 | 116 |
| 2026 | 4 | 152 |
The 11 FDA applicant names in this group
| Applicant name | 510(k) clearances | PMA | De Novo | Years |
|---|---|---|---|---|
| Fresenius Medical Care Renal Therapies Group, LLC | 52 | 0 | 0 | 2013–2026 |
| Nxstage Medical, Inc. | 51 | 0 | 0 | 2001–2024 |
| Fresenius Medical Care North America | 42 | 0 | 0 | 1998–2025 |
| Fresenius USA, Inc. | 38 | 0 | 0 | 1984–1999 |
| Fresenius Medical Care | 7 | 0 | 0 | 2000–2024 |
| Fresenius Medical Care North America, Design Cente | 5 | 0 | 0 | 2010–2013 |
| Fresenius Medical Care South Asia Pacific Pty , Ltd. | 2 | 0 | 0 | 2009–2011 |
| Fresenius Medical Care, North America - Renal Ther | 1 | 0 | 0 | 2014–2014 |
| Fresenius Medical Care Reanal Therapies Group, LLC | 1 | 0 | 0 | 2020–2020 |
| Fresenius Medical Care Rental Therapies Group, LLC | 1 | 0 | 0 | 2022–2022 |
| Fresenius Medical Care-North America | 1 | 0 | 0 | 2012–2012 |
Review time against the same product codes
Since 2017, 510(k)s cleared under these names took a median 168 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 180 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| KDI | Dialyzer, High Permeability With Or Without Sealed Dialysate System | 75 | 75 |
| KPO | Dialysate Concentrate For Hemodialysis (Liquid Or Powder) | 24 | 24 |
| KDJ | Set, Administration, For Peritoneal Dialysis, Disposable | 10 | 10 |
| KOC | Accessories, Blood Circuit, Hemodialysis | 10 | 10 |
| FKP | System, Dialysate Delivery, Single Patient | 9 | 9 |
| FKX | System, Peritoneal, Automatic Delivery | 9 | 9 |
| FIP | Subsystem, Water Purification | 8 | 8 |
| FJK | Set, Tubing, Blood, With And Without Anti-Regurgitation Valve | 8 | 8 |
| FKR | Subsystem, Proportioning | 5 | 5 |
| LKN | Separator, Automated, Blood Cell And Plasma, Therapeutic | 4 | 4 |
Plus 26 more product codes.
Review panels
- Gastroenterology and Urology (183)
- Cardiovascular (6)
- Clinical Chemistry (4)
- Dental (2)
- General Hospital (2)
- Physical Medicine (2)
Most recent Fresenius Medical Care 510(k) clearances
| 510(k) | Device | Applicant name | Product code | Decision date | Review days |
|---|---|---|---|---|---|
| K261267 | Careflux H60;Careflux H70;Careflux V500 | Fresenius Medical Care Renal Therapies Group, LLC | KDI | 2026-07-24 | 99 |
| K252377 | NxStage System One with NxView | Fresenius Medical Care Renal Therapies Group, LLC | KDI | 2026-05-15 | 289 |
| K252459 | multiFlux 130 (F00013123); multiFlux 160 (F00013124) | Fresenius Medical Care Renal Therapies Group, LLC | KDI | 2026-02-10 | 189 |
| K253462 | NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2) | Fresenius Medical Care Renal Therapies Group, LLC | KPO | 2026-01-29 | 114 |
| K253518 | FX CorAL 40; FX CorAL 50 | Fresenius Medical Care Renal Therapies Group, LLC | KDI | 2025-12-18 | 36 |
| K250634 | BCM2-Body Composition Monitor | Fresenius Medical Care Renal Therapies Group, LLC | DSB | 2025-11-24 | 266 |
| K250471 | AquaC UNO H | Fresenius Medical Care Renal Therapies Group, LLC | FIP | 2025-11-14 | 269 |
| K251851 | DIASAFEplusUS (F00013010) | Fresenius Medical Care Renal Therapies Group, LLC | FIP | 2025-10-09 | 115 |
| K252181 | AquaA | Fresenius Medical Care North America | FIP | 2025-09-09 | 60 |
| K252180 | Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby Dialysate RFP-403 (RFP-403-G); Bicarby Dialysate RFP-453 (RFP-453-W); Bicarby Dialysate RFP-453 (RFP-453-G); Bicarby Dialysate RFP-454 (RFP-454-W); Bicarby Dialysate RFP-454 (RFP-454-G); Bicarby Dialysate RFP-456 (RFP-456-W) | Fresenius Medical Care Renal Therapies Group, LLC | KPO | 2025-09-09 | 60 |
191 earlier clearances. See the full list in Caduvo.
Recalls
82 product recalls in 44 recall events under these names; 11 initiated in the last five years.
Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
How this group is built
Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.
Fresenius Medical Care and its US arm Fresenius USA, plus NxStage (2019). Includes filings made before the acquisition. Left out: Fresenius Kabi (a separate Fresenius SE business).
Sources
Frequently asked questions
How many FDA 510(k) clearances are listed across Fresenius Medical Care's applicant names?
FDA lists 201 510(k) clearances, 0 PMA and 0 De Novo decisions across the 11 applicant names Caduvo groups under Fresenius Medical Care, first 1984, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.
Which FDA applicant names does Fresenius Medical Care file under?
The names with the most 510(k) clearances in this group are Fresenius Medical Care Renal Therapies Group, LLC (52); Nxstage Medical, Inc. (51); Fresenius Medical Care North America (42); Fresenius USA, Inc. (38); Fresenius Medical Care (7). The full list of 11 names is on this page.
How long does FDA take to clear Fresenius Medical Care 510(k)s?
The median time from FDA receipt to decision across 510(k)s cleared under these names is 116 days. Since 2017 the median was 168 days, against 180 days for all cleared 510(k)s in the same product codes.
Does the Fresenius Medical Care count include acquired companies?
Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.
Next steps
- See all 201 Fresenius Medical Care clearances with predicates and recalls
- Run predicate analysis for product code KDI, Fresenius Medical Care's most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls). Applicant names are matched exactly, with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this grouping or data.
All parent companies · FDA device companies by applicant name · FDA product code lookup